Name: UMIN ID:
Unique ID issued by UMIN | UMIN000026129 |
---|---|
Receipt number | R000029759 |
Scientific Title | The prospective study of nivolumab for advanced NSCLC patients with mild IIPs |
Date of disclosure of the study information | 2017/02/15 |
Last modified on | 2022/01/09 08:15:57 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/02/14 14:38:10 | ||
2 | Update | 2017/02/14 14:40:22 | Date of disclosure of the study information |
|
3 | Update | 2017/10/21 19:12:26 | Condition Condition |
|
4 | Update | 2018/04/08 17:48:33 | Institutions |
|
5 | Update | 2018/07/03 14:48:59 | Recruitment status |
|
6 | Update | 2018/12/29 19:30:55 | Date trial data considered complete |
|
7 | Update | 2020/02/17 10:51:42 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
8 | Update | 2020/02/17 10:54:11 | Number of participants that the trial has enrolled Results Results Results date posted |
|
9 | Update | 2020/02/17 10:59:40 | Recruitment status Date of IRB Last follow-up date |
|
10 | Update | 2020/02/17 11:04:07 | URL releasing protocol Publication of results URL related to results and publications Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
11 | Update | 2022/01/09 08:15:57 | Recruitment status |